Findings

What do systematic reviews say?

839 questions · 881 findings · 73 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 246 · 27.9%GRADE not reported 156 · 17.7%Very low 219 · 24.9%Low 136 · 15.4%Moderate 90 · 10.2%High 34 · 3.9%

Yoga vs no intervention

Anxiety (state) · UC patients

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Very low

Yoga vs no intervention

Anxiety (trait) · UC patients

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Very low

Kefir ( Lactobacillus bacteria) vs no intervention

Treatment success as defined by the authors · UC patients

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Kefir ( Lactobacillus bacteria) vs no intervention

Pain frequency or change in pain frequency · UC patients

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Kefir ( Lactobacillus bacteria) vs no intervention

Pain intensity (measure on a 0‐3 four‐point scale) · UC patients

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
Very low

Low FODMAP diet vs sham diet

Pain frequency or change in pain frequency · UC patients

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 26 participants
Very low

Kefir ( Lactobacillus bacteria) vs no intervention

Withdrawals due to adverse events · UC patients

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
GRADE not reported

Stellate ganglion block vs sulphasalazine

Treatment success as defined by the authors · UC patients

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Stellate ganglion block vs sulphasalazine

Pain frequency or change in pain frequency · UC patients

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Stellate ganglion block vs sulphasalazine

Pain intensity (measure on a 0‐3 four‐point scale) · UC patients

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Stellate ganglion block vs sulphasalazine

Withdrawals due to adverse events · UC patients

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Low FODMAP diet vs sham diet

Pain intensity (0‐10cm visual analogue scale) · UC patients

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 26 participants
Very low

Low FODMAP diet vs sham diet

Withdrawals due to adverse events · UC patients

It is very uncertain whether low FODMAPs diet changes withdrawal due to adverse events compared with sham diet (very low certainty).

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
RR 1.85
1 study · 52 participants
Very low

Relaxation vs WAIT LIST

Treatment success as defined by the authors · UC patients

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Relaxation vs WAIT LIST

Pain frequency or change in pain frequency · UC patients

2 findings from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Very low
Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Very low

Relaxation vs WAIT LIST

Pain intensity (end of intervention, unidentified 0‐10 scale) · UC patients

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Very low

Relaxation vs WAIT LIST

Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · UC patients

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Very low

Oral 5‐aminosalicylic acid vs placebo

Failure to maintain clinical or endoscopic remission · Patients with quiescent ulcerative colitis

Oral 5‐aminosalicylic acid leads to lower failure to maintain clinical or endoscopic remission compared with placebo (high certainty).

1 finding from 1 review

Oral 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
RR 0.68 [0.61, 0.76]
8 studies · 1555 participants
High

Once daily dosing vs conventional dosing

Failure to maintain clinical or endoscopic remission · Patients with quiescent ulcerative colitis

Once‐daily dosing showed no clear difference in failure to maintain clinical or endoscopic remission compared with conventional dosing (high certainty).

1 finding from 1 review

Oral 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
RR 0.94 [0.88, 1.01]
10 studies · 3910 participants
High

Once daily dosing vs conventional dosing

Failure to adhere to medication regimen · Patients with quiescent ulcerative colitis

Once‐daily dosing showed no clear difference in failure to adhere to study medication regimen compared with conventional dosing (moderate certainty).

1 finding from 1 review

Oral 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
RR 1.18 [0.72, 1.93]
9 studies · 2306 participants
Moderate